Rimola A, García-Tsao G, Navasa M, 외. (January 2000). “Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club”. 《J. Hepatol.》 32 (1): 142–53. doi:10.1016/S0168-8278(00)80201-9. PMID10673079.
Gati GA, Deshpande A (2012). “Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression”. 《Clinical Gastroenterology and Hepatology》 10 (4): 422–27. doi:10.1016/j.cgh.2011.11.019. PMID22155557.
Deshpande A, Pasupuleti V (2012). “Acid suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis”. 《Journal of Gastroenterology and Hepatology》 28 (2): 235–42. doi:10.1111/jgh.12065. PMID23190338. S2CID25099491.
Runyon BA, Morrissey RL, Hoefs JC, Wyle FA (1985). “Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis”. 《Hepatology》 5 (4): 634–7. doi:10.1002/hep.1840050419. PMID4018735. S2CID9665518.
Ruiz, S; Soto, S; Rodado, R; Alcaraz, F; López Guillén, E (September 2007). “[Spontaneous bacterial peritonitis as form of presentation of idiophatic nephrotic syndrome in a black adult].”. 《Anales de Medicina Interna》 24 (9): 442–4. doi:10.4321/s0212-71992007000900008. PMID18198954.
Hiyama, T.; Yoshihara, M.; Tanaka, S.; Haruma, K.; Chayama, K. (Apr 2009). “Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract.”. 《J Gastroenterol Hepatol》 24 (4): 537–46. doi:10.1111/j.1440-1746.2009.05780.x. PMID19220673.
Sort P, Navasa M, Arroyo V, 외. (1999). “Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis”. 《N. Engl. J. Med.》 341 (6): 403–9. doi:10.1056/NEJM199908053410603. PMID10432325.
Rimola A, García-Tsao G, Navasa M, 외. (January 2000). “Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club”. 《J. Hepatol.》 32 (1): 142–53. doi:10.1016/S0168-8278(00)80201-9. PMID10673079.
Gati GA, Deshpande A (2012). “Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression”. 《Clinical Gastroenterology and Hepatology》 10 (4): 422–27. doi:10.1016/j.cgh.2011.11.019. PMID22155557.
Deshpande A, Pasupuleti V (2012). “Acid suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis”. 《Journal of Gastroenterology and Hepatology》 28 (2): 235–42. doi:10.1111/jgh.12065. PMID23190338. S2CID25099491.
Runyon BA, Morrissey RL, Hoefs JC, Wyle FA (1985). “Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis”. 《Hepatology》 5 (4): 634–7. doi:10.1002/hep.1840050419. PMID4018735. S2CID9665518.
Ruiz, S; Soto, S; Rodado, R; Alcaraz, F; López Guillén, E (September 2007). “[Spontaneous bacterial peritonitis as form of presentation of idiophatic nephrotic syndrome in a black adult].”. 《Anales de Medicina Interna》 24 (9): 442–4. doi:10.4321/s0212-71992007000900008. PMID18198954.
Hiyama, T.; Yoshihara, M.; Tanaka, S.; Haruma, K.; Chayama, K. (Apr 2009). “Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract.”. 《J Gastroenterol Hepatol》 24 (4): 537–46. doi:10.1111/j.1440-1746.2009.05780.x. PMID19220673.
Sort P, Navasa M, Arroyo V, 외. (1999). “Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis”. 《N. Engl. J. Med.》 341 (6): 403–9. doi:10.1056/NEJM199908053410603. PMID10432325.
Deshpande A, Pasupuleti V (2012). “Acid suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis”. 《Journal of Gastroenterology and Hepatology》 28 (2): 235–42. doi:10.1111/jgh.12065. PMID23190338. S2CID25099491.